Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy

被引:99
作者
Shariat, SF
Anwuri, VA
Lamb, DJ
Shah, NV
Wheeler, TM
Slawin, KM
机构
[1] Univ Texas, SW Med Sch, Dept Urol, Dallas, TX 75230 USA
[2] Methodist Hosp, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pathol & Mol & Cellular Biol, Houston, TX 77030 USA
[4] Baylor Coll Med, Scott Dept Urol, Div Male Reprod Med & Surg, Houston, TX 77030 USA
[5] Baylor Coll Med, Baylor Prostate Ctr, Houston, TX 77030 USA
关键词
D O I
10.1200/JCO.2004.09.142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Angiogenesis is a critical process for cancer progression. We tested whether elevated circulating levels of the angiogenesis-related markers vascular endothelial growth factor (VEGF) and/or soluble vascular cell adhesion molecule-1 (sVCAM-1) are associated with prostate cancer diagnosis, stage, progression, and metastasis. Patients and Methods Plasma levels of VEGF and sVCAM-1 were measured on frozen, archival plasma obtained preoperatively from 215 consecutive patients who underwent radical prostatectomy for clinically localized disease, nine men with untreated prostate cancer metastatic to bones, and 40 healthy men without cancer. Results Plasma levels of both VEGF and sVCAM-1 were highest in patients with bone metastases (P <.001). VEGF levels were higher in patients with clinically localized disease than in healthy controls (P <.001). VEGF levels were elevated in patients with biopsy and final Gleason sum greater than or equal to 7 (P =.036 and P =.020, respectively) and extraprostatic extension (P =.047). Higher preoperative VEGF was independently associated with metastases to lymph nodes (P <.001). Both VEGF and sVCAM-1 were independently associated with biochemical progression after adjustment for the effects of standard preoperative features (P =.014 and P =.039, respectively). VEGF remained independently associated with biochemical progression after adjustment for standard postoperative features (P =.019). Conclusion Plasma levels of VEGF increased incrementally from healthy controls to patients with clinically localized disease to patients with lymph node and skeletal metastases. Higher preoperative VEGF was independently associated with metastases to lymph nodes and biochemical progression after surgery in both pre- and postoperative models, Plasma sVCAM-1 was elevated in men with bone metastases and was associated with biochemical progression in a preoperative model.
引用
收藏
页码:1655 / 1663
页数:9
相关论文
共 75 条
[1]  
Adams J, 2000, CANCER RES, V60, P2898
[2]   Angiogenesis as a potential biomarker in prostate cancer chemoprevention trials [J].
Ali, IU ;
Senger, DR ;
Smith, LEH .
UROLOGY, 2001, 57 (4A) :143-147
[3]  
Arai Y, 1996, Int J Urol, V3, P373, DOI 10.1111/j.1442-2042.1996.tb00556.x
[4]   Is a limited lymph node dissection an adequate staging procedure for prostate cancer? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2002, 168 (02) :514-518
[5]   Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? [J].
Bader, P ;
Burkhard, FC ;
Markwalder, R ;
Studer, UE .
JOURNAL OF UROLOGY, 2003, 169 (03) :849-854
[6]   Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology [J].
Banks, RE ;
Forbes, MA ;
Kinsey, SE ;
Stanley, A ;
Ingham, E ;
Walters, C ;
Selby, PJ .
BRITISH JOURNAL OF CANCER, 1998, 77 (06) :956-964
[7]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[8]   COMPARISON OF MICROSCOPIC VASCULARITY IN BENIGN AND MALIGNANT PROSTATE TISSUE [J].
BIGLER, SA ;
DEERING, RE ;
BRAWER, MK .
HUMAN PATHOLOGY, 1993, 24 (02) :220-226
[9]  
Borgström P, 1998, PROSTATE, V35, P1
[10]   Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies [J].
Bostwick, DG ;
Wheeler, TM ;
Blute, M ;
Barrett, DM ;
MacLennan, GT ;
Sebo, TJ ;
Scardino, PT ;
Humphrey, PA ;
Hudson, MA ;
Fradet, Y ;
Miller, GJ ;
Crawford, ED ;
Blumenstein, BA ;
Mahran, HE ;
Miles, BJ .
UROLOGY, 1996, 48 (01) :47-57